Zivo Bioscience, Inc. company info

CIK 1101026
IRS Number 870699977
State of incorporation NV
Business address 2804 ORCHARD LAKE ROAD, SUITE 202
Mail address 2804 ORCHARD LAKE ROAD, SUITE 202

Short summary

Zivo Bioscience, Inc. is a Michigan company, with head office located at 2804 Orchard Lake Road, Suite 202 Keego Harbor, Michigan 48320. In 2019 the company owned a total of 178.92 thousand USD worth of assets, including 178.92 thousand USD worth of current assets. 2013 was the year when the company amassed the most assets.

Zivo Bioscience, Inc. Income Statement

Name [in Millions USD]20092010201120122013201420152016201720182019Trends
Revenue, Net 0.080.090
Research and development 0.400.380.681.021.971.030.792.382.812.31
Amortization of Acquired Intangible Assets 0.000.01
Operating Expenses
Operating Income (Loss) -4.06-1.94-2.08-3.11-5.15-3.06-3.49-6.33-6.13-8.35
Interest expense -0.01-0.05-0.14-0.44-0.590.72-0.04
Net income -7.12-2.73-3.25-10.100.68-5.79-6.06-10.04-14.64-11.51

Zivo Bioscience, Inc. Balance Sheet

Name [in Millions USD]20092010201120122013201420152016201720182019Trends
Cash and cash equivalents
Accounts Receivable, Net, Current 0.02
Inventories 0.030
Deferred income taxes 7.50
Property, Plant and Equipment, Gross 0.320.320.
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment -0.26-0.040.07-
Other Assets, Noncurrent 0.130.13
Total assets 0.390.360.501.540.
Current assets
Non-current assets 0.200.11
Accounts payable 0.460.720.800.681.191.110.760.451.171.82
Total current liabilities 0.862.538.715.917.196.342.6219.5811.279.33
Deferred Revenue, Noncurrent 0.230.2400
Total liabilities 1.493.509.116.558.0711.2116.7819.5811.279.33
Common Stock, Value, Issued
Retained Earnings (Accumulated Deficit) -27.31-31.07-38.19-39.31-45.22-51.40-57.06-71.23-84.04-92.50

Zivo Bioscience, Inc. Cash Flow

Name [in Millions USD]20092010201120122013201420152016201720182019Trends
Net income -7.12-2.73-3.25-10.100.68-5.79-6.06-10.04-14.64-11.51
Depreciation and amortization
Amortization of Intangible Assets
Depreciation and amortization
Depreciation and amortization 0.090.07
Inventories -0.010.010
Accounts payable -
Deferred revenue 0.25-0.020-0.240
Net Cash Provided by (Used in) Operating Activities -1.44-1.29-1.77-2.99-2.74-2.30-2.54-4.24-5.01-3.71
Payments to Acquire Property, Plant, and Equipment -0.03-0.00-0.000
Payments to Acquire Intangible Assets 0-0.330
Net Cash Provided by (Used in) Investing Activities -0.03-0.00-0.00-0.33000000
Proceeds from Issuance of Long-term Debt 0.020.24
Proceeds from Issuance of Common Stock 1.180.6203.432.65
Net Cash Provided by (Used in) Financing Activities 1.481.511.603.762.242.313.
Cash and Cash Equivalents, Period Increase (Decrease) 0.020.21-0.180.45-0.490.020.49